62 related articles for article (PubMed ID: 7633884)
1. In vivo detection of immunoreactive neurokinin A release within rat substantia nigra and its dependency on a dopaminergic input.
Furmidge LJ; Duggan AW; Arbuthnott GW
Brain Res; 1995 May; 679(2):241-8. PubMed ID: 7633884
[TBL] [Abstract][Full Text] [Related]
2. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
[TBL] [Abstract][Full Text] [Related]
3. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
Humpel C; Saria A
Neurosci Lett; 1989 Oct; 105(1-2):159-63. PubMed ID: 2484728
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo release of neurokinin A-like immunoreactivity from rat substantia nigra.
Diez-Guerra FJ; Sirinathsinghji DJ; Emson PC
Neuroscience; 1988 Nov; 27(2):527-36. PubMed ID: 2905788
[TBL] [Abstract][Full Text] [Related]
5. In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats.
Sarre S; Yuan H; Jonkers N; Van Hemelrijck A; Ebinger G; Michotte Y
J Neurochem; 2004 Jul; 90(1):29-39. PubMed ID: 15198664
[TBL] [Abstract][Full Text] [Related]
6. Evidence that neurokinin A (substance K) neurons project from the striatum to the substantia nigra in rats.
Nagashima A; Takano Y; Masui H; Kamiya H
Neurosci Lett; 1987 Jun; 77(1):103-8. PubMed ID: 3037449
[TBL] [Abstract][Full Text] [Related]
7. Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra.
Lindefors N; Brodin E; Ungerstedt U
Eur J Pharmacol; 1989 Feb; 161(1):95-8. PubMed ID: 2470596
[TBL] [Abstract][Full Text] [Related]
8. Depletion in substance P- and neurokinin A-like immunoreactivity in substantia nigra after ibotenate-induced lesions of striatum.
Arai H; Sirinathsinghji DJ; Emson PC
Neurosci Res; 1987 Dec; 5(2):167-71. PubMed ID: 2448711
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic treatment induces region-specific changes in levels of neurokinin A and substance P in rat brain.
Lindefors N; Brodin E; Ungerstedt U
Neuropeptides; 1986 Apr; 7(3):265-80. PubMed ID: 2423911
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
[TBL] [Abstract][Full Text] [Related]
11. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
Greenfield SA; Grünewald RA; Foley P; Shaw SG
J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
[TBL] [Abstract][Full Text] [Related]
12. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
13. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
[TBL] [Abstract][Full Text] [Related]
14. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
15. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat.
Ojeda V; Fuentealba JA; Galleguillos D; Andrés ME
J Neurosci Res; 2003 Sep; 73(5):686-97. PubMed ID: 12929136
[TBL] [Abstract][Full Text] [Related]
16. Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A.
Brodin E; Lindefors N; Dalsgaard CJ; Theodorsson-Norheim E; Rosell S
Regul Pept; 1986 Feb; 13(3-4):253-72. PubMed ID: 2422706
[TBL] [Abstract][Full Text] [Related]
17. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat.
Bolam JP; Smith Y
Brain Res; 1990 Oct; 529(1-2):57-78. PubMed ID: 1704287
[TBL] [Abstract][Full Text] [Related]
18. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
[TBL] [Abstract][Full Text] [Related]
19. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
[TBL] [Abstract][Full Text] [Related]
20. Tachykinins in the rat substantia nigra: effects of selective dopamine receptor antagonists.
Oblin A; Zivkovic B
Fundam Clin Pharmacol; 1991; 5(2):129-38. PubMed ID: 1712746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
